rs149879790

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001009944.3(PKD1):​c.8109C>T​(p.Thr2703Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00121 in 1,591,226 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0038 ( 4 hom., cov: 20)
Exomes 𝑓: 0.00095 ( 9 hom. )

Consequence

PKD1
NM_001009944.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -1.87
Variant links:
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 16-2104550-G-A is Benign according to our data. Variant chr16-2104550-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 257010.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2104550-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-1.87 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00375 (563/150032) while in subpopulation AFR AF= 0.0105 (425/40436). AF 95% confidence interval is 0.00969. There are 4 homozygotes in gnomad4. There are 285 alleles in male gnomad4 subpopulation. Median coverage is 20. This position pass quality control queck.
BS2
High AC in GnomAd4 at 563 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PKD1NM_001009944.3 linkuse as main transcriptc.8109C>T p.Thr2703Thr synonymous_variant 22/46 ENST00000262304.9 NP_001009944.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PKD1ENST00000262304.9 linkuse as main transcriptc.8109C>T p.Thr2703Thr synonymous_variant 22/461 NM_001009944.3 ENSP00000262304.4 P98161-1

Frequencies

GnomAD3 genomes
AF:
0.00376
AC:
564
AN:
149914
Hom.:
4
Cov.:
20
show subpopulations
Gnomad AFR
AF:
0.0105
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00139
Gnomad ASJ
AF:
0.000868
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000424
Gnomad FIN
AF:
0.00599
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000607
Gnomad OTH
AF:
0.00387
GnomAD3 exomes
AF:
0.00135
AC:
213
AN:
157772
Hom.:
0
AF XY:
0.00124
AC XY:
106
AN XY:
85150
show subpopulations
Gnomad AFR exome
AF:
0.0108
Gnomad AMR exome
AF:
0.000428
Gnomad ASJ exome
AF:
0.000946
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000854
Gnomad FIN exome
AF:
0.00480
Gnomad NFE exome
AF:
0.000608
Gnomad OTH exome
AF:
0.000903
GnomAD4 exome
AF:
0.000949
AC:
1368
AN:
1441194
Hom.:
9
Cov.:
30
AF XY:
0.000938
AC XY:
672
AN XY:
716124
show subpopulations
Gnomad4 AFR exome
AF:
0.0130
Gnomad4 AMR exome
AF:
0.000508
Gnomad4 ASJ exome
AF:
0.00101
Gnomad4 EAS exome
AF:
0.000204
Gnomad4 SAS exome
AF:
0.000262
Gnomad4 FIN exome
AF:
0.00466
Gnomad4 NFE exome
AF:
0.000480
Gnomad4 OTH exome
AF:
0.00146
GnomAD4 genome
AF:
0.00375
AC:
563
AN:
150032
Hom.:
4
Cov.:
20
AF XY:
0.00389
AC XY:
285
AN XY:
73232
show subpopulations
Gnomad4 AFR
AF:
0.0105
Gnomad4 AMR
AF:
0.00139
Gnomad4 ASJ
AF:
0.000868
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000425
Gnomad4 FIN
AF:
0.00599
Gnomad4 NFE
AF:
0.000607
Gnomad4 OTH
AF:
0.00383
Alfa
AF:
0.000612
Hom.:
0
Bravo
AF:
0.00398

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Likely benign, criteria provided, single submitterclinical testingGeneDxOct 05, 2020- -
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Polycystic kidney disease, adult type Benign:1
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesOct 01, 2018- -
Polycystic kidney disease Benign:1
Likely benign, no assertion criteria providedclinical testingDepartment of Pathology and Laboratory Medicine, Sinai Health System-The PKD1 p.Thr2703= variant was not identified in the literature nor was it identified in the LOVD 3.0 or PKD1-LOVD databases. The variant was identified in dbSNP (ID: rs149879790) as "With Likely benign allele", ClinVar (classified as likely benign by PreventionGenetics), and ADPKD Mutation Database (as likely neutral by Athena Diagnostics). The variant was identified in control databases in 330 of 181400 chromosomes at a frequency of 0.002, increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 180 of 15966 chromosomes (freq: 0.01), Other in 3 of 4834 chromosomes (freq: 0.0006), Latino in 12 of 25804 chromosomes (freq: 0.0005), European in 41 of 73996 chromosomes (freq: 0.0006), Ashkenazi Jewish in 6 of 8472 chromosomes (freq: 0.0007), Finnish in 86 of 15602 chromosomes (freq: 0.006), and South Asian in 2 of 23480 chromosomes (freq: 0.00009); it was not observed in the East Asian population. The p.Thr2703= variant is not expected to have clinical significance because it does not result in a change of amino acid and occurs at a non-highly conserved nucleotide at a known consensus splice site. In addition, in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.92
DANN
Benign
0.77

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs149879790; hg19: chr16-2154551; API